In advance of this year’s TAPPI Nanotechnology Division Conference in Montreal, Canada, (June 5th-8th, 2017) Vireo Advisors will be hosting a half-day workshop on Monday June 5 aimed at small-, mid-, and large-sized enterprises interested in the health, safety and environmental aspects of working with bio-based and nanoscale materials.

"NanoCRED: A transparent framework to assess' the regulatory adequacy of ecotoxicity data for nanomaterials – Relevance and reliability revisited", by Hartmann, et al., was released in March 2017 (Science Direct).

The Atlanta based American Process, Inc. and Italian biochemical company,  GFBiochemicals have signed a JDA, along with other members of the consortium,  to create the largest integrated cellulosic biorefinery in the world.

TheNational Academies of Science, Engineering, and Medicine (NAS) were asked to form a committee in response to the order from the Executive Office of President in July 2015, in which the EPA, FDA, and USDA were charged with the responsibility of analyzing "the future of biotechnologies in regards to potential new risks and frameworks for risk assessment and areas in which risks or lack of risks relating to the products of biotechnology are well understood."

Vireo Advisors, in collaboration with American Process Inc. (API), published the article “Establishing the safety of novel bio-based cellulose nanomaterials for commercialization” in the journal NanoImpact that demonstrates how to proactively develop an industrially relevant safety testing plan for nanomaterials.